Scheme for Strengthening of Medical Device Industry (SMDI) - Marginal Investment Scheme for Reducing Import Dependence (MISRID)
Department of Pharmaceuticals · Central government · Verified 3 August 2026
The SMDI capital subsidy scheme funds domestic manufacturing of key medical device components and raw materials to cut import dependency.
Closed. Applications closed on 24 July 2026. The details below describe the most recent cycle.
Key facts
- Grant size
- Up to ₹10 crore
- Funding type
- Subsidy
- Deadline
- 24 July 2026
- Disbursement
- Reimbursed after spend
About this program
The Department of Pharmaceuticals, under the Ministry of Chemicals & Fertilizers, Government of India, runs the Scheme for Strengthening of Medical Device Industry (SMDI). Within this framework, the Marginal Investment Scheme for Reducing Import Dependence (MISRID) targets the domestic production of components, raw materials, and accessories used in medical device manufacturing, including in-vitro diagnostics (IVDs). Historically, the Indian medical device sector has depended on imported inputs, creating supply chain vulnerabilities and raising production expenses. The scheme offers financial incentives to encourage domestic firms to invest in manufacturing these essential items.
The initiative aims to build a self-sufficient manufacturing base for medical devices, supporting the production of high-quality and affordable products. It focuses on localising key inputs such as sensors, embedded systems, optical filters, electrodes, and medical-grade materials. This effort is intended to stimulate innovation, generate employment, and position India as a global manufacturing destination for medical devices. It aligns with the 'Make in India' vision and supports public health by securing the availability of essential devices domestically, particularly during global health emergencies.
Who can apply
- Eligible organisation types
- All nonprofit forms
- 12A registration
- Not specified
- 80G registration
- Not specified
- CSR-1 registration
- Not specified
- FCRA registration
- Not specified
- NGO Darpan ID
- Not specified
- Where the NGO may be based
- Not restricted
- Open to Central/State Government organisations, companies/LLPs, and Special Purpose Vehicles (SPVs) registered under the Companies Act or Societies Registration Act in India.
- Medical device/in-vitro diagnostic manufacturers with existing facilities, or those planning to produce key components, input materials, or accessories, are eligible.
- Manufacturers of critical raw materials (e.g., polymer, glass, metal, textile, paper for medical grade use) qualify.
- Importers intending to shift to manufacturing any medical device or IVD on the GTE list may apply.
How to apply
Go to the official SMDI portal at https://smdi.lsssdc.in/.
Open the section for the Marginal Investment Scheme for Reducing Import Dependence (MISRID).
Register your organisation and complete the online application form with all requested information.
Attach the necessary supporting documents, which generally include company registration certificates, financial statements, a detailed project proposal, investment plans, and technical specifications of the components or materials to be produced.
Submit the application by the deadline of July 24, 2026.
Track the application’s progress through the portal and address any clarifications raised by the scheme administrators.
Applicants who are shortlisted move on to the evaluation stages, which comprise a technical review and committee appraisals.
How applications are assessed
Applications are evaluated in stages to determine how well they meet the scheme's objectives. The first step is an appraisal by the Project Management Agency (PMA), which checks that submissions are complete and meet the basic eligibility criteria. After this, a Technical Committee examines the technical feasibility, innovation, and strategic relevance of each proposed manufacturing project. The final decision rests with the Scheme Steering Committee, which grants approval only to projects that support the broader aims of strengthening the medical device industry and reducing reliance on imports.
Frequently asked questions
What is the primary objective of the MISRID scheme?
The scheme aims to boost local manufacturing of essential components, raw materials, and accessories—including those for in-vitro diagnostic devices—thereby cutting India's reliance on imported inputs.
Who is eligible to apply for this scheme?
Eligible applicants are Central or State Government organisations, companies or LLPs registered in India, and Special Purpose Vehicles (SPVs) registered under the Companies Act or Societies Registration Act. This includes manufacturers of medical devices, IVDs, critical raw materials, and importers planning to move into manufacturing.
What is the maximum subsidy amount I can receive?
The maximum capital subsidy is ₹10 Crore, paid on a reimbursement basis. The applicable rate—20%, 15%, or 10%—depends on the company's annual turnover, with smaller firms receiving a higher percentage of their investment.
What kind of activities are eligible for this subsidy?
Eligible activities cover the production of key components, raw materials, and accessories for medical devices and IVDs, including sensors, embedded systems, optical filters, electrodes, antigens/antibodies, polymer tubing, metal tubing, and medical-grade packaging materials.
Is co-financing required for this scheme?
Yes. Because the incentive is a capital subsidy disbursed on a reimbursement basis, you must first fund the investment yourself, and only a percentage of that amount will be repaid, so co-financing is required.
What is the project completion timeline?
Projects approved under the scheme must be completed within two years of final approval. A one-year extension is possible in specific circumstances.
Focus areas
- Health Pharma Biotech
- Medical Devices
- Healthcare Manufacturing
- Import Substitution
- Capital Subsidy
- Invitro Diagnostics
- Pharmaceuticals
Details last verified on 3 August 2026. Source: the funder's published information.
Related funding
Medical Device Clinical Studies Support Scheme (MDCSSS) - SMDI
Department of Pharmaceuticals
A government scheme reimbursing up to ₹5 crore for clinical studies of medical devices and IVDs made in India.
- Grant size
- Up to ₹5 crore
- Deadline
- 24 July 2026
Health Pharma Biotech · Medical Devices · Clinical Studies · Healthcare
SheConnects Digital Accelerator India 2026 (Round 2)
Reliance Foundation
Grants and support for not-for-profits scaling proven solutions to advance women's digital inclusion across India.
- Grant size
- ₹85 lakh – ₹4.2 crore
- Deadline
- 4 September 2026
- Time left
- 19 days
Fintech · Health Pharma Biotech · Agri Food Rural · Edtech
The Wellcome Prize for Mental Health Science with Nature
Wellcome
The Wellcome-Nature Mental Health Prize funds groundbreaking mental health science, awarding up to ₹9.52 crore to the winner and ₹2.38 crore to finalists, plus visibility and support.
- Grant size
- ₹2.38 crore – ₹9.53 crore
- Deadline
- 15 September 2026
- Time left
- 29 days
Health Pharma Biotech · Social Impact · Mental Health · Science